Brief: Cullinan Therapeutics Announces Submission Of Investigational New Drug Application To U.S. Food And Drug Administration For Cln-978 To Treat Systemic Lupus Erythematosus
16/09/2024 12:38
Sept 16 (Reuters) - Cullinan Therapeutics Inc CGEM.O :
* CULLINAN THERAPEUTICS ANNOUNCES SUBMISSION OF
INVESTIGATIONAL
NEW DRUG APPLICATION TO U.S. FOOD AND DRUG ADMINISTRATION FOR
CLN-978 TO TREAT SYSTEMIC LUPUS ERYTHEMATOSUS
Source text for Eikon: ID:nGNX4kY5jd
Further company coverage: CGEM.O
((Reuters.Briefs@thomsonreuters.com;))